1st Quarter - Amendment

ALKERMES, INC. for ALKERMES, INC.

Period 1st Quarter 2012 Filed May 3, 2012 Signed by Kathryn L. Biberstein

Official filing
Firm
ALKERMES, INC.
Client
ALKERMES, INC.
Income
—
Expenses
$39,944
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provider education programs and other educational resources related to Vivitrol.

LobbyistCovered position, as disclosed
ROBERT FORMAN —

Contacted: SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.